Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 3Other hematologic neoplasm 3Myeloid 3Lymphoid 3Sarcoma 1Gynecologic 1Genitourinary 1Dermatologic 1CNS 1Breast 1

Conditions

Dendritic Cell Sarcoma, Interdigitating 22Lymphoma, Large B-Cell, Diffuse 12Lymphoma 11Lymphoma, Non-Hodgkin 8Burkitt Lymphoma 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Recurrence 5Lymphoma, Mantle-Cell 5Lymphoma, Follicular 5Myelodysplastic Syndromes 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, B-Cell, Marginal Zone 3Leukemia, Myelomonocytic, Juvenile 3Leukemia, Myeloid, Acute 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Leukemia, Lymphocytic, Chronic, B-Cell 3Waldenstrom Macroglobulinemia 2Sarcoma, Myeloid 2Neoplasms 2Multiple Myeloma 2Leukemia, Hairy Cell 2Leukemia 2Hodgkin Disease 2HIV Infections 2Breast Neoplasms 2Wilms Tumor 1Triple Negative Breast Neoplasms 1Testicular Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1

Interventions

Cyclophosphamide 10fludarabine phosphate 9Mycophenolic Acid 8Antilymphocyte Serum 8Cyclosporine 7Methotrexate 6Filgrastim 6Cord Blood Stem Cell Transplantation 6Busulfan 6Tacrolimus 5Peripheral Blood Stem Cell Transplantation 5Whole-Body Irradiation 4Radiotherapy 4Methylprednisolone 4Melphalan 4Etoposide 3thymoglobulin 2Sirolimus 2Polymerase Chain Reaction 2Flow Cytometry 2Amplified Fragment Length Polymorphism Analysis 2sargramostim 1liposomal amphotericin B 1Voriconazole 1Valacyclovir 1Stem Cell Transplantation 1Rituximab 1Prednisone 1Pentetic Acid 1Ondansetron 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pdgfra-Associated Chronic Eosinophilic Leukemia × Rituximab × Sarcoma × Clear all
NCT00617929 2017-12-28

Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant

Masonic Cancer Center, University of Minnesota

Phase 2 Terminated
12 enrolled 12 charts
BreastCNSGenitourinaryGynecologicLymphoidMyeloidOther hematologic neoplasmPlasma cellSarcoma

Pdgfra-Associated Chronic Eosinophilic Leukemia, Carcinoma, Ovarian Epithelial, Breast Neoplasms, Burkitt Lymphoma, Hodgkin Disease, Leukemia, Hairy Cell, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Neoplasms, Wilms Tumor, Neuroblastoma, Recurrence, Rhabdomyosarcoma, Testicular Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Neutrophilic, Chronic, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡